title: Erythrocyte sodium-lithium countertransport activity as a marker of predisposition to hypertension and diabetic nephropathy in NIDDM.
abstract: OBJECTIVE
  To evaluate the potentiality of erythrocyte sodium-lithium countertransport activity (SLC) as a marker of predisposition to hypertension and diabetic nephropathy in non-insulin-dependent diabetes mellitus (NIDDM).
  
  
  METHODS
  We examined 96 patients with NIDDM and 26 healthy control subjects. SLC and other data were compared among subgroups of the patients classified on the basis of hypertension, family history of hypertension, and stages of nephropathy. Data were also analyzed by stepwise multiple regression analyses.
  
  
  RESULTS
  SLC was significantly higher in patients with hypertension than in those with normotension and significantly higher in patients with a positive family history of hypertension than in the negative group. Further analysis revealed that a family history of hypertension has independent influence on SLC, but hypertension itself does not. SLC was significantly higher in patients with macroalbuminuria than with microalbuminuria and higher in patients with microalbuminuria than with normalbuminuria. In stepwise multiple regression analyses, a family history of hypertension was the most important determinant of SLC, and SLC was the most important determinant of nephropathy.
  
  
  CONCLUSIONS
  These data suggest that SLC strongly reflects a predisposition to hypertension and that it can be a useful marker of diabetic nephropathy in NIDDM.
authors.affiliation: Department of Metabolism and Clinical Nutrition, Kyoto University Faculty of Medicine, Japan.
authors.forename: J
authors.initials: J
authors.lastname: Fujita
authors.forename: K
authors.initials: K
authors.lastname: Tsuda
authors.forename: M
authors.initials: M
authors.lastname: Seno
authors.forename: H
authors.initials: H
authors.lastname: Obayashi
authors.forename: I
authors.initials: I
authors.lastname: Fukui
authors.forename: Y
authors.initials: Y
authors.lastname: Seino
mesh_terms: D000328:Adult; D017920:Antiporters / Q000032:analysis* / Q000502:physiology; D001685:Biological Factors / Q000097:blood; D001794:Blood Pressure / Q000502:physiology; D015984:Causality; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications* / Q000503:physiopathology; D003928:Diabetic Nephropathies / Q000097:blood / Q000453:epidemiology* / Q000503:physiopathology; D004912:Erythrocytes / Q000737:chemistry* / Q000166:cytology / Q000502:physiology; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000453:epidemiology* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D012044:Regression Analysis
chemical_list: D017920:Antiporters; D001685:Biological Factors; C045885:sodium-lithium countertransporter